Provention Bio Inc. (PRVB) is priced at $4.77 after the most recent trading session. At the very opening of the session, the stock price was $5.14 and reached a high price of $5.14, prior to closing the session it reached the value of $5.06. The stock touched a low price of $4.77.Recently in News on January 7, 2022, Provention Bio Announces the Grant of Inducement Awards. Provention Bio, Inc. (Nasdaq: PRVB) (the “Company”), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company granted stock options to Randy Anderson, Senior Vice President of Biometrics to purchase an aggregate of 130,000 shares of common stock. The stock options were granted without stockholder approval as inducements, material to Mr. Anderson entering into employment with the Company pursuant to Nasdaq Listing Rule 5635(c)(4) and were approved by the Company’s compensation committee of the board of directors. You can read further details here
Provention Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.05 on 01/03/22, with the lowest value was $4.77 for the same time period, recorded on 01/12/22.
Provention Bio Inc. (PRVB) full year performance was -75.48%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Provention Bio Inc. shares are logging -76.21% during the 52-week period from high price, and -3.44% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.94 and $20.05.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 499835 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Provention Bio Inc. (PRVB) recorded performance in the market was -15.12%, having the revenues showcasing -25.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 315.01M, as it employees total of 59 workers.
Provention Bio Inc. (PRVB) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.32, with a change in the price was noted -1.20. In a similar fashion, Provention Bio Inc. posted a movement of -20.10% for the period of last 100 days, recording 546,518 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PRVB is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Provention Bio Inc. (PRVB): Stocks Technical analysis and Trends
Raw Stochastic average of Provention Bio Inc. in the period of last 50 days is set at 0.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.00%. In the last 20 days, the company’s Stochastic %K was 7.89% and its Stochastic %D was recorded 7.69%.
If we look into the earlier routines of Provention Bio Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.12%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -23.92%, alongside a downfall of -75.48% for the period of the last 12 months. The shares increased approximately by -13.59% in the 7-day charts and went up by -22.56% in the period of the last 30 days. Common stock shares were lifted by -25.35% during last recorded quarter.